164 related articles for article (PubMed ID: 37663943)
41. The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion.
van Golen RF; Reiniers MJ; Marsman G; Alles LK; van Rooyen DM; Petri B; Van der Mark VA; van Beek AA; Meijer B; Maas MA; Zeerleder S; Verheij J; Farrell GC; Luken BM; Teoh NC; van Gulik TM; Murphy MP; Heger M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1192-1200. PubMed ID: 30658161
[TBL] [Abstract][Full Text] [Related]
42. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells.
Panzarini E; Inguscio V; Fimia GM; Dini L
PLoS One; 2014; 9(8):e105778. PubMed ID: 25140900
[TBL] [Abstract][Full Text] [Related]
43. Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.
Angelova AL; Grekova SP; Heller A; Kuhlmann O; Soyka E; Giese T; Aprahamian M; Bour G; Rüffer S; Cziepluch C; Daeffler L; Rommelaere J; Werner J; Raykov Z; Giese NA
J Virol; 2014 May; 88(10):5263-76. PubMed ID: 24574398
[TBL] [Abstract][Full Text] [Related]
44. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.
Fucikova J; Truxova I; Hensler M; Becht E; Kasikova L; Moserova I; Vosahlikova S; Klouckova J; Church SE; Cremer I; Kepp O; Kroemer G; Galluzzi L; Salek C; Spisek R
Blood; 2016 Dec; 128(26):3113-3124. PubMed ID: 27802968
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of DAMP signaling as an effective adjunctive treatment strategy in pneumococcal meningitis.
Masouris I; Klein M; Dyckhoff S; Angele B; Pfister HW; Koedel U
J Neuroinflammation; 2017 Nov; 14(1):214. PubMed ID: 29096648
[TBL] [Abstract][Full Text] [Related]
46. Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer.
Kim R; Kin T
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638242
[TBL] [Abstract][Full Text] [Related]
47. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
48. Biomarkers of Radiotherapy-Induced Immunogenic Cell Death.
Vaes RDW; Hendriks LEL; Vooijs M; De Ruysscher D
Cells; 2021 Apr; 10(4):. PubMed ID: 33920544
[TBL] [Abstract][Full Text] [Related]
49. Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma.
McShane R; Arya S; Stewart AJ; Caie PD; Bates M
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188598. PubMed ID: 34332022
[TBL] [Abstract][Full Text] [Related]
50. Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy.
Xu M; Lu JH; Zhong YZ; Jiang J; Shen YZ; Su JY; Lin SY
Front Oncol; 2022; 12():870914. PubMed ID: 35444934
[TBL] [Abstract][Full Text] [Related]
51. Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical Cancer.
Oltean T; Lippens L; Lemeire K; De Tender C; Vuylsteke M; Denys H; Vandecasteele K; Vandenabeele P; Adjemian S
Front Oncol; 2022; 12():892813. PubMed ID: 35903697
[TBL] [Abstract][Full Text] [Related]
52. Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.
Aoto K; Mimura K; Okayama H; Saito M; Chida S; Noda M; Nakajima T; Saito K; Abe N; Ohki S; Ohtake T; Takenoshita S; Kono K
Oncol Rep; 2018 Jan; 39(1):151-159. PubMed ID: 29138861
[TBL] [Abstract][Full Text] [Related]
53. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
[TBL] [Abstract][Full Text] [Related]
54. Expression of neuroepithelial transforming gene 1 is enhanced in oesophageal cancer and mediates an invasive tumour cell phenotype.
Lahiff C; Cotter E; Casey R; Doran P; Pidgeon G; Reynolds J; Macmathuna P; Murray D
J Exp Clin Cancer Res; 2013 Aug; 32(1):55. PubMed ID: 23945136
[TBL] [Abstract][Full Text] [Related]
55. Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.
Bibby BAS; Miranda CS; Reynolds JV; Cawthorne CJ; Maher SG
BMC Cancer; 2019 Aug; 19(1):784. PubMed ID: 31391080
[TBL] [Abstract][Full Text] [Related]
56. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
Inoue H; Tani K
Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
[TBL] [Abstract][Full Text] [Related]
57. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
58. DAMPs from Cell Death to New Life.
Vénéreau E; Ceriotti C; Bianchi ME
Front Immunol; 2015; 6():422. PubMed ID: 26347745
[TBL] [Abstract][Full Text] [Related]
59. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review.
Zhai J; Gu X; Liu Y; Hu Y; Jiang Y; Zhang Z
Front Pharmacol; 2023; 14():1152934. PubMed ID: 37153795
[TBL] [Abstract][Full Text] [Related]
60. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells.
Calvet CY; Famin D; André FM; Mir LM
Oncoimmunology; 2014; 3():e28131. PubMed ID: 25083316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
